These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34839258)

  • 1. Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy.
    Kim AH; Jang JE; Han J
    Biomed Pharmacother; 2022 Jan; 145():112463. PubMed ID: 34839258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction.
    Tromp J; Lim SL; Tay WT; Teng TK; Chandramouli C; Ouwerkerk W; Wander GS; Sawhney JPS; Yap J; MacDonald MR; Ling LH; Sattar N; McMurray JJV; Richards AM; Anand I; Lam CSP;
    Diabetes Care; 2019 Sep; 42(9):1792-1799. PubMed ID: 31292141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
    Seferović PM; Paulus WJ
    Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure in diabetes.
    Jankauskas SS; Kansakar U; Varzideh F; Wilson S; Mone P; Lombardi A; Gambardella J; Santulli G
    Metabolism; 2021 Dec; 125():154910. PubMed ID: 34627874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
    Hölscher ME; Bode C; Bugger H
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline.
    Julián MT; Alonso N; Lupón J; Gavidia-Bovadilla G; Ferrer E; de Antonio M; López-Ayerbe J; Domingo M; Santiago-Vacas E; Zamora E; Codina P; Moliner P; Núñez J; Santesmases J; Puig-Domingo M; Bayes-Genis A
    Cardiovasc Diabetol; 2020 Mar; 19(1):38. PubMed ID: 32293458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation.
    Polovina M; Lund LH; Đikić D; Petrović-Đorđević I; Krljanac G; Milinković I; Veljić I; Piepoli MF; Rosano GMC; Ristić AD; Ašanin M; Seferović PM
    Eur J Heart Fail; 2020 Jan; 22(1):113-125. PubMed ID: 31822042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction.
    Lin SN; Phang KK; Toh SH; Chee KH; Zaman Huri H
    Front Endocrinol (Lausanne); 2020; 11():448. PubMed ID: 32754118
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diabetes and heart failure: a practically oriented critical appraisal].
    Halle M; Gitt AK; Hanefeld M; Kellerer M; Marx N; Meier JJ; Schumm-Draeger PM; Bramlage P; Tschoepe D
    Dtsch Med Wochenschr; 2012 Mar; 137(9):437-41. PubMed ID: 22354800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
    van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
    Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Failure and Diabetes: Perspective of a Dangerous Association.
    Favaloro LE; Ratto RD; Musso C
    Curr Hypertens Rev; 2021; 17(2):85-93. PubMed ID: 33823781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments.
    Iwakura K
    J Echocardiogr; 2019 Dec; 17(4):177-186. PubMed ID: 31617144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction.
    Walker AM; Patel PA; Rajwani A; Groves D; Denby C; Kearney L; Sapsford RJ; Witte KK; Kearney MT; Cubbon RM
    Diab Vasc Dis Res; 2016 Sep; 13(5):331-40. PubMed ID: 27334485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design.
    Savarese G; Settergren C; Schrage B; Thorvaldsen T; Löfman I; Sartipy U; Mellbin L; Meyers A; Farsani SF; Brueckmann M; Brodovicz KG; Vedin O; Asselbergs FW; Dahlström U; Cosentino F; Lund LH
    Int J Cardiol; 2020 Aug; 313():76-82. PubMed ID: 32360702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction.
    Kim MN; Park SM
    Heart Fail Clin; 2021 Jul; 17(3):463-482. PubMed ID: 34051977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity-related heart failure with preserved ejection fraction: new treatment strategies.
    Chrysant SG; Chrysant GS
    Hosp Pract (1995); 2019 Apr; 47(2):67-72. PubMed ID: 30712418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
    Chandra A; Vaduganathan M; Lewis EF; Claggett BL; Rizkala AR; Wang W; Lefkowitz MP; Shi VC; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV; Solomon SD;
    JACC Heart Fail; 2019 Oct; 7(10):862-874. PubMed ID: 31302043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
    Marwick TH; Ritchie R; Shaw JE; Kaye D
    J Am Coll Cardiol; 2018 Jan; 71(3):339-351. PubMed ID: 29348027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.